Ingrid Borges Perez, Esq.’s Post

Really great article here. There's a ton of potential from advancements in liquid biopsy technology for cancer care. Early detection and treatment are key to cancer survival, and that's an area it's proving highly successful in. But Gebra Cuyun Carter and Caitlin Kubler point out a disappointing fact: "Research is already showing that liquid biopsy for selecting treatment is falling into well-established patterns of use." As we move towards integrating liquid biopsy into standard care, addressing these disparities is key to ensuring that innovations like this benefit all patients equitably. Collaboration among stakeholders will be essential to mitigate these risks and promote fair access across diverse populations. #PrecisionMedicine #Healthcare #HealthEquity

Remote patient monitoring & advantages 💡from saving patients time and improving convenience 💡through giving patients access to doctors when needed via telemedicine visits 💡to being more environmentally friendly due to cutting commute CO2 These are only selected examples. Very interesting to see this data Cristina! #remotetrials #telemedicine #digitalhealth #healthtrends #patientcare

Remote monitoring and data collection are pivotal for decentralized clinical trials (DCTs): - Enhancing Trial Accessibility and Participation: Remote monitoring and data collection eliminate geographical barriers, enabling more patients to participate in clinical trials, especially those who cannot easily access trial centers. This helps expand the sample size, improve data representativeness, and enhance the reliability of trial results. - Reducing Trial Costs and Time: Decentralized clinical trials typically reduce time and cost burdens for both researchers and patients, as patients do not need to frequently visit trial centers. This also reduces the need for physical trial facilities, thus lowering the overall cost of trials. - Improving Real-time and Accurate Data: Remote monitoring and data collection enable real-time collection of patient physiological parameters, symptoms, and treatment responses, providing researchers with more timely and accurate information. This helps in early detection of patient condition changes, thereby improving trial monitoring and management efficiency. - Protecting Patient Privacy and Data Security: Remote monitoring and data collection must strictly adhere to data privacy and security standards to protect patients' personal information and data security. Researchers need to take necessary measures to ensure the security and confidentiality of data to mitigate the risk of data breaches or misuse. - Facing Challenges and Limitations: Such as the requirements for technical devices, patient acceptance of digital technology, data collection consistency, and standardization. Additionally, for certain diseases or specific populations, remote monitoring may not fully replace traditional clinical observation and examination.

Remote patient monitoring in #cancer trials : we can expect a more broader use for a better #patient experience and a better access equity to trials in the coming years #clinicalresearch #decentralizedtrials

Funding announced to boost development of health tech for cancer - Digital Health #FundingAnnouncedForCancerHealthTech The UK government has announced funding to support the development of health technology specifically for cancer treatment and care. This funding aims to accelerate the innovation and adoption of digital solutions in the fight against cancer. #UKGovernmentFunding #HealthTechnologyDevelopment #FocusOnEarlyDetection One of the key areas of focus for the funding is early detection of cancer through the use of advanced technologies. By investing in tools and platforms that can detect cancer at an early stage, the goal is to improve patient outcomes and survival rates. #EarlyDetectionTechnology #ImprovedPatientOutcomes #PersonalizedTreatmentApproaches Another important aspect of the funding is the development of personalized treatment approaches for cancer patients. By leveraging data ai.mediformatica.com #cancer #government #medical #funding #health #innovation #investment #partners #scanners #technology #departmentofscience #diagnosis #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4gSmIFU)

COTA and Texas Oncology’s Precision Health Informatics, LLC collaborate to use #AI in transforming healthcare data into actionable insights, enhancing #precisionmedicine and #cancer care. Read at The Evidence Base® #rwe #rwd #realworldevidence #realworlddata #healthdata #electronichealthrecords #EHRs #oncology #artificialintelligence

Lung cancer poses a major challenge that involves multiple approaches for early identification, personalized treatment, and continuous research. To defeat this tough opponent, we must work together, combining gentle care with medical advancements to achieve better results. The fight against lung cancer is becoming more intense, and data analytics is taking the forefront because it provides a multitude of information that goes beyond the diagnosis and treatment process. Lung cancer care is changing as a result of the collaboration between data-driven discoveries and healthcare, which provides accuracy and hope at every stage of the procedure. 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭: 𝐃𝐚𝐭𝐚-𝐃𝐫𝐢𝐯𝐞𝐧 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐄𝐚𝐫𝐥𝐲 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧: Data analytics transforms lung cancer diagnosis by interpreting subtle patterns in medical imaging, guaranteeing the early detection of abnormalities that may indicate the existence of tumors. 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐆𝐮𝐢𝐝𝐞𝐬 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬: By examining the genetic terrain, data analytics offers a therapy plan that takes into account each patient's distinct genetic profile while dealing with lung cancer. 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐧𝐠 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐰𝐢𝐭𝐡 𝐆𝐫𝐞𝐚𝐭 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧: Analytics builds predictive models by utilizing past data, enabling medical professionals to anticipate and modify treatment for the best possible outcomes for patients with lung cancer. 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐢𝐬𝐤 𝐄𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐑𝐚𝐩𝐢𝐝 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧: By analyzing patient data, data analytics generates a stratified risk assessment that enables early and personalized interventions, leading to better predictions and more efficient solutions to lung cancer challenges. 𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐬 𝐀𝐬𝐬𝐢𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐧𝐬𝐢𝐛𝐥𝐞 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬: Data analytics provides oncologists with comprehensive profiles by seamlessly combining clinical and patient records. This information serves as a guide for informed decision-making in the complex field of lung cancer diagnosis and treatment. Data analytics provides light on the route to personalized and efficient care in the fight against lung cancer. The facts revealed are more than just data collection; they are a source of optimism, advancement, and a revitalized sense of empowerment for people struggling with the complexities of lung cancer. #dataanalytics #dataanalysis #transformation #healthcareindustry #lungcancerawareness #diagnosis #solutions #technology #trends #intelliquity

Health technology is revolutionizing healthcare, and companies like LINDA, a Toronto startup, are leading the way. Their use of contactless screening technology to detect breast cancer early is remarkable. This breakthrough not only enhances accessibility but also empowers doctors to identify cancer more effectively. It's inspiring to witness how technology is positively impacting patient outcomes. #healthtech #digitalhealth

Dr. Keegan Duchicela, M.D. has firsthand experience evaluating for cancer risk in patients during 15-minute PCP visits. The short of it? Assessing for cancer risk in a routine PCP setting is challenging, complex, and...fast. Alongside Wendy McKennon, Chief Product Innovation Officer at Color, Keegan has written about how AI tools can help synthesize critical information for clinicians. Here's how our new copilot, created with OpenAI, is designed to help PCPs navigate cancer screening recommendations, detection, and care—all while adhering to a "human in the loop" model. ⤵ https://lnkd.in/gDabKQq4

Avenda Health Introduces Unfold AI | Revolutionizing Prostate Cancer Care - DistilINFO Hospital IT Avenda Health Introduces Unfold AI | Revolutionizing Prostate Cancer Care #AvendaHealth: Avenda Health, a healthcare technology company, has introduced Unfold AI, a revolutionary tool that is set to transform the way prostate cancer care is delivered. #UnfoldAI: Unfold AI is a cutting-edge technology developed by Avenda Health, designed to enhance the accuracy and efficiency of prostate cancer treatment. #ProstateCancerCare: Unfold AI promises to revolutionize prostate cancer care by providing personalized treatment plans based on individual patient data and predictive analytics. #Benefits: The benefits of Unfold AI include improved treatment outcomes, reduced side effects, and increased patient satisfaction. #HowItWorks: Unfold AI utilizes advanced algorithms to ai.mediformatica.com #cancer #prostate #prostatecancer #health #avendahealth #clinical #clinicians #patients #cancercare #management #platform #data #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3TNiB4E)